Industry News
Mathematical 'Gingko trees' reveal mutations in single cells that characterize diseases
9/08/2015
Online app could help clinicians choose the best treatments by comparing genetic fingerprints of individual cellsSeemingly similar cells often have significantly different genomes.
Drug that prevents chemotherapy-induced nausea and vomiting wins FDA approval
9/08/2015
Regulators have approved Varubi (rolapitant) to prevent delayed phase chemotherapy-induced nausea and vomiting, a side effect that can disrupt patients' lives and their therapy.
Deadly melanoma discovery supports immunotherapy treatment for cancer
9/08/2015
Research into desmoplastic melanoma by an international team of scientists based at UCSF points toward immunotherapy as an effective approach to treating cancer.
Researchers uncover biomarker that may help predict stomach cancer survival
9/08/2015
A new study from China identifies an important biomarker in stomach cancer lesions that gives patients a more reliable indicator of their survival rates.
Cancer Drugs Fund removes funding for two life-prolonging myeloma drugs, UK
9/04/2015
As part of a second reassessment of the Cancer Drugs Fund, NHS England has announced that Imnovid® (pomalidomide) and Revlimid® (lenalidomide) at first relapse for the rare bone marrow...
How can aspirin help to cure cancer?
9/04/2015
Studies have suggested aspirin and other NSAIDs may help fight cancer if used alongside other immunotherapy treatments. Now, new research adds to the evidence.
Esophageal cancer: Positron emission tomography does not improve treatment
9/04/2015
Patients with cancer of the esophagus--also known as the gullet--are often given chemo- or radiotherapy, with the aim of shrinking the tumor before it is surgically removed.
Prostate cancer: should PSA screening be routine?
9/04/2015
In 2012, the USPSTF made a recommendation against routine PSA testing for prostate cancer - a move met with criticism. We look at the evidence for and against such testing.
Targeting newly discovered pathway sensitizes tumors to radiation and chemotherapy
9/04/2015
In some patients, aggressive cancers can become resistant to chemotherapy and radiation treatments.
Variations in cell programs control cancer and normal stem cells
9/04/2015
In the breast, cancer stem cells and normal stem cells can arise from different cell types but tap into distinct yet related stem cell programs, according to Whitehead Institute researchers.